SCHEMBL28129196

SCHEMBL28129196

O=C(c1cc(F)c(O)c(I)c1)c1cc(F)c(O)c(I)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EYA3 Q99504 2/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ TTR P02766 8/20 0.39
▸ CES2 O00748 2/20 0.38
▸ CES1 P23141 2/20 0.38
▸ FASN P49327 1/20 0.37
▸ ESR1 P03372 2/20 0.37
▸ TPMT P51580 1/20 0.37
▸ CYP2C9 P11712 1/20 0.36
▸ ERN1 O75460 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ BIRC5 O15392 1/20 0.36
▸ ABCB11 O95342 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ ADRA2A P08913 1/20 0.36
▸ DRD1 P21728 1/20 0.36
▸ TBXA2R P21731 1/20 0.36
▸ PTGS1 P23219 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1313079 0.85 TPMT (0.56) TTRTPMTERN1LMNA
SCHEMBL5303103 0.84 TTR (0.52) EYA3CYP2C19TTRESR1TPMT
SCHEMBL28151234 0.84 CES2 (0.46) TTRCES2CES1FASNESR1
SCHEMBL1312438 0.79 KDM4E (0.58) CYP2C19ESR1TPMTCYP2C9ERN1
SCHEMBL6723795 0.78 TTR (0.51) EYA3CYP2C19TTRCES2CES1
SCHEMBL28104789 0.74 CYP2C9 (0.37) EYA3CYP2C19TTRESR1TPMT
SCHEMBL6724575 0.74 MAPT (0.56) EYA3CYP2C19TTRCES2CES1
SCHEMBL7197434 0.72 AKR1B1 (0.61) FASNMEN1LMNAKMT2AAKR1B1
SCHEMBL6732706 0.72 TPMT (0.46) EYA3CYP2C19TTRESR1TPMT
SCHEMBL6720720 0.72 LMNA (0.62) EYA3CYP2C19TTRESR1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106432229-A Compounds for treating or preventing hyperuricemia or gout 江苏新元素医药科技有限公司 2017-02-22 — — CN claimed
CN-106432229-A Compounds for treating or preventing hyperuricemia or gout 江苏新元素医药科技有限公司 2017-02-22 — — CN disclosed
Send feedback